Blood Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Application Region and Competition, 2020-2030F

Description

Global Blood Preparation Market was valued at USD 43.57 billion in 2024 and is expected to reach USD 62.57 billion by 2030 with a CAGR of 6.22% during the forecast period. The Global Blood Preparation Market is a dynamic and critical component of the healthcare and pharmaceutical industry, encompassing a wide range of products and services aimed at ensuring the availability and safety of blood and blood-related products for various medical applications. This market revolves around the processing, testing, and distribution of blood components, plasma, and other blood derivatives, vital for life-saving transfusions, therapeutic treatments, and research. With a growing emphasis on patient safety, the demand for advanced and high-quality blood preparation products and services has been steadily increasing.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 43.57 Billion
Market Size 2030	USD 62.57 Billion
CAGR 2025-2030	6.22%
Fastest Growing Segment	Blood Derivatives
Largest Market	North America

Key Market Drivers

Prevalence of Chronic Diseases

The prevalence of chronic diseases is a primary driver behind the rapid growth of the Global Blood Preparation Market. Chronic diseases, which encompass a wide range of conditions such as cancer, anemia, hemophilia, and blood disorders, often necessitate frequent blood transfusions as an integral part of their management and treatment. This demand for blood and blood-related products is escalating due to the increasing global burden of chronic diseases.

As populations age and lifestyles become increasingly sedentary, the incidence of chronic diseases continues to rise. Conditions like diabetes, cardiovascular diseases, and cancer have become more common, leading to a growing need for blood preparations. For instance, cancer patients often require regular blood transfusions to manage the anemia and low platelet counts associated with chemotherapy, while individuals with blood disorders like sickle cell anemia depend on blood transfusions to alleviate their symptoms and complications.

Key Market Challenges

Stringent Regulatory Compliance

The Global Blood Preparation Market, a crucial pillar of healthcare, faces a formidable challenge in the form of stringent regulatory compliance. While regulations are essential to ensuring the safety and efficacy of blood and blood-related products, the stringent nature of these requirements can impede the market's growth and operational efficiency.

Blood preparation involves a complex set of processes, from collection and testing to storage and distribution. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), set stringent standards that must be met to guarantee the safety and quality of blood products. These standards encompass numerous facets of the blood preparation process, including donor eligibility criteria, testing protocols, documentation, and the maintenance of storage and transportation conditions.

Meeting these rigorous regulatory requirements can be a resource-intensive endeavor, particularly for smaller blood banks and healthcare providers. Compliance demands substantial investments in state-of-the-art equipment, quality control measures, staff training, and infrastructure. These expenses can be cost-prohibitive for smaller organizations, potentially limiting their ability to participate in the market. Furthermore, the constant need to adapt to evolving regulations places an ongoing financial burden on stakeholders within the blood preparation industry.

Key Market Trends

Technological Advancements in Blood Preparation

Technological advancements in blood preparation are playing a pivotal role in boosting the Global Blood Preparation Market. Automation, sophisticated equipment, and innovative methods have ushered in a new era of efficiency, safety, and quality within the industry. These advancements are reshaping the landscape of blood collection, processing, and storage, leading to an enhanced market with numerous benefits for healthcare providers and patients alike.

Automation, in particular, stands out as a game-changer in the field. Automated blood preparation systems have revolutionized the industry by significantly reducing human error, enhancing precision, and accelerating the speed at which blood components can be prepared. Automated equipment can process large volumes of blood with unmatched precision, resulting in a more consistent and reliable supply of blood products. This not only improves operational efficiency but also reduces the margin of error, ensuring that the final products meet the highest quality and safety standards.

Moreover, innovative methods and technologies have paved the way for more advanced testing and screening processes. The introduction of nucleic acid testing (NAT), for instance, has significantly enhanced the sensitivity and accuracy of detecting infectious agents, such as HIV, hepatitis B and C. This improvement in blood safety has instilled greater confidence among healthcare professionals and the public, reassuring them that blood products are less likely to transmit infections or other complications.

Key Market Players

Pfizer, Inc.
Bristol-Myers Squibb Company
Leo Pharma A/S
Sanofi
Xiamen Hisunny Chemical Co., LTD
AstraZeneca plc
Baxter International Inc
Portola Pharmaceuticals, Inc.
GlaxoSmithKline PLC
Shandong East Chemical Industry Co.

Report Scope:

In this report, the Global Blood Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Preparation Market, By Product:

Whole Blood
Blood Components
Blood Derivatives

Blood Preparation Market, By Type:

Platelet Aggregation Inhibitors
Fibrinolytics
Anticoagulants

Blood Preparation Market, By Application:

Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others

Blood Preparation Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Preparation Market.

Available Customizations:

Global Blood Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Preparation Market Outlook

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. Market Share & Forecast
- 4.2.1. By Product (Whole Blood, Blood Components, Blood Derivatives)
- 4.2.2. By Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants)
- 4.2.3. By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others)
- 4.2.4. By Region
- 4.2.5. By Company (2024)
4.3. Market Map
- 4.3.1. By Product
- 4.3.2. By Type
- 4.3.3. By Application
- 4.3.4. By Region

5. Asia Pacific Blood Preparation Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Type
- 5.2.3. By Application
- 5.2.4. By Country
5.3. Asia Pacific: Country Analysis
- 5.3.1. China Blood Preparation Market Outlook
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Product
    - 5.3.1.2.2. By Type
    - 5.3.1.2.3. By Application
- 5.3.2. India Blood Preparation Market Outlook
  - 5.3.2.1. Market Size & Forecast
    - 5.3.2.1.1. By Value
  - 5.3.2.2. Market Share & Forecast
    - 5.3.2.2.1. By Product
    - 5.3.2.2.2. By Type
    - 5.3.2.2.3. By Application
- 5.3.3. Australia Blood Preparation Market Outlook
  - 5.3.3.1. Market Size & Forecast
    - 5.3.3.1.1. By Value
  - 5.3.3.2. Market Share & Forecast
    - 5.3.3.2.1. By Product
    - 5.3.3.2.2. By Type
    - 5.3.3.2.3. By Application
- 5.3.4. Japan Blood Preparation Market Outlook
  - 5.3.4.1. Market Size & Forecast
    - 5.3.4.1.1. By Value
  - 5.3.4.2. Market Share & Forecast
    - 5.3.4.2.1. By Product
    - 5.3.4.2.2. By Type
    - 5.3.4.2.3. By Application
- 5.3.5. South Korea Blood Preparation Market Outlook
  - 5.3.5.1. Market Size & Forecast
    - 5.3.5.1.1. By Value
  - 5.3.5.2. Market Share & Forecast
    - 5.3.5.2.1. By Product
    - 5.3.5.2.2. By Type
    - 5.3.5.2.3. By Application

6. Europe Blood Preparation Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Type
- 6.2.3. By Application
- 6.2.4. By Country
6.3. Europe: Country Analysis
- 6.3.1. France Blood Preparation Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Type
    - 6.3.1.2.3. By Application
- 6.3.2. Germany Blood Preparation Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Type
    - 6.3.2.2.3. By Application
- 6.3.3. Spain Blood Preparation Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Type
    - 6.3.3.2.3. By Application
- 6.3.4. Italy Blood Preparation Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Product
    - 6.3.4.2.2. By Type
    - 6.3.4.2.3. By Application
- 6.3.5. United Kingdom Blood Preparation Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Product
    - 6.3.5.2.2. By Type
    - 6.3.5.2.3. By Application

7. North America Blood Preparation Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Type
- 7.2.3. By Application
- 7.2.4. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Blood Preparation Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By Application
- 7.3.2. Mexico Blood Preparation Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By Application
- 7.3.3. Canada Blood Preparation Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By Application

8. South America Blood Preparation Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By Application
- 8.2.4. By Country
8.3. South America: Country Analysis
- 8.3.1. Brazil Blood Preparation Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By Application
- 8.3.2. Argentina Blood Preparation Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By Application
- 8.3.3. Colombia Blood Preparation Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By Application

9. Middle East and Africa Blood Preparation Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By Application
- 9.2.4. By Country
9.3. MEA: Country Analysis
- 9.3.1. South Africa Blood Preparation Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By Application
- 9.3.2. Saudi Arabia Blood Preparation Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By Application
- 9.3.3. UAE Blood Preparation Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By Application

10. Market Dynamics

10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Blood Preparation Market: SWOT Analysis

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape

14.1. Pfizer, Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Current Capacity Analysis
- 14.1.5. Financials (In case of listed)
- 14.1.6. Recent Developments
- 14.1.7. SWOT Analysis
14.2. Bristol-Myers Squibb Company
14.3. Leo Pharma A/S
14.4. Sanofi
14.5. Xiamen Hisunny Chemical Co., LTD
14.6. AstraZeneca plc
14.7. Baxter International Inc
14.8. Portola Pharmaceuticals, Inc.
14.9. GlaxoSmithKline PLC
14.10.Shandong East Chemical Industry Co.